W Al-Khyatt

Learn More
INTRODUCTION A Cochrane review of seven randomised trials (N=1571) comparing surgery and primary endocrine therapy (PET) (oestrogen receptor (ER) unselected) shows no difference in overall survival (OS). We report outcome of a large series with ER-positive (ER+) early invasive primary breast cancer. METHODS Between 1973 and 2009, 1065 older (≥ 70 years)(More)
  • 1